Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusheng Jie

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2023
Subcellular localization and relevant mechanisms of human cancer-related micropeptidesJing Deng, Wenli Xu, Yusheng Jie, et al.
Discover Oncology|June 13, 2025
MASP1 in stomach adenocarcinoma: linking diagnosis, prognosis, and tumor immunityChuyu Xiao, Fuyang Hong, Guanzi Chen, et al.
Journal of Clinical and Translational Hepatology|January 22, 2024
Single-cell Technologies Provide Novel Insights into Liver Physiology and PathologyGuanzi Chen, Wenli Xu, Zhicong Long, et al.
Biomed Research International|April 2, 2016
Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNAHong Shi, Mingxing Huang, Guoli Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2020
Inappropriate cessation of nucleos(t)ide analog associated with reduced liver transplant-free survival in patients with HBV-related acute on chronic liver failureHong Shi, Gemin Xiao, Mei Liao, et al.
Biomed Research International|July 23, 2020
A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis BYaqiong Chen, Jiao Gong, Wenying Zhou, et al.
Biomed Research International|June 29, 2017
TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in ChinaMingxing Huang, Guoli Lin, Hong Shi, et al.
Global Health Research and Policy|January 21, 2024
Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling studyJinzhao Xie, Xu Wang, Xinran Wang, et al.
Hepatology International|July 24, 2015
Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation studyYusheng Jie, Xiangyong Li, Guoli Lin, et al.
Mycoses|May 24, 2019
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort studyZhanyi Li, Yu Liu, Yutian Chong, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2023
Subcellular localization and relevant mechanisms of human cancer-related micropeptidesJing Deng, Wenli Xu, Yusheng Jie, et al.
Discover Oncology|June 13, 2025
MASP1 in stomach adenocarcinoma: linking diagnosis, prognosis, and tumor immunityChuyu Xiao, Fuyang Hong, Guanzi Chen, et al.
Journal of Clinical and Translational Hepatology|January 22, 2024
Single-cell Technologies Provide Novel Insights into Liver Physiology and PathologyGuanzi Chen, Wenli Xu, Zhicong Long, et al.
Biomed Research International|April 2, 2016
Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNAHong Shi, Mingxing Huang, Guoli Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2020
Inappropriate cessation of nucleos(t)ide analog associated with reduced liver transplant-free survival in patients with HBV-related acute on chronic liver failureHong Shi, Gemin Xiao, Mei Liao, et al.
Biomed Research International|July 23, 2020
A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis BYaqiong Chen, Jiao Gong, Wenying Zhou, et al.
Biomed Research International|June 29, 2017
TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in ChinaMingxing Huang, Guoli Lin, Hong Shi, et al.
Global Health Research and Policy|January 21, 2024
Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling studyJinzhao Xie, Xu Wang, Xinran Wang, et al.
Hepatology International|July 24, 2015
Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation studyYusheng Jie, Xiangyong Li, Guoli Lin, et al.
Mycoses|May 24, 2019
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort studyZhanyi Li, Yu Liu, Yutian Chong, et al.
Pageof 6